EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mesenchymal progenitor–derived proteoglycan 4 regulates the transdifferentiation of chondrocytes into osteoblasts during fracture healing

Nicoletta Ninkovic, Jessica May Corpuz, Alana Stahl, Alexandra Olsen, Colton M Unger, Aria Ahadzadeh Ardebili, Haochen Sun, Juyeon Cha, Daphne Kaketsis, Sarah L Manske, Ifaz T Haider, Ralph S Marcucio und 7 weitere

Stem Cells Translational Medicine · 11.09.2025 · 14 (9)

DOI: 10.1093/stcltm/szaf043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 19.09.2025. Verfasst von Nicoletta Ninkovic und 18 weiteren Autor:innen. Beteiligte Einrichtung: McCaig Institute for Bone & Joint Health, University of Calgary, Calgary, AB T2N4N1, Canada. Hauptthemen laut MEDLINE: Fracture Healing, Mesenchymal Stem Cells, Proteoglycans, Osteoblasts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Sciences and Engineering Research Council (NSERC), Canada Foundation for Innovation, Calgary Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Proteoglycan 4 (PRG4), also known as lubricin, is essential for maintaining tissue homeostasis and acts as a lubricant that protects joint surfaces from wear and tear. Our previous studies have demonstrated that PRG4 plays multiple roles in wound healing in mice and pigs. Specifically, PRG4 derived from Hic1+ mesenchymal progenitor cells (MPCs) is crucial for maintaining tissue homeostasis in the dura mater near the spinal cord, and in the skin it contributes to ear wound healing in mice. Additionally, mice lacking PRG4 exhibit abnormal bone structure and function. However, the role of PRG4 in fracture healing remains unclear.

Methods

To investigate the role of PRG4 in fracture repair, we generated mice with a conditional deletion of Prg4 in the Hic1+ lineage. The presence and contribution of Hic1+ progenitors at the fracture site were assessed at 2‑ and 4‑weeks post‑injury (wpi). Bone healing quality was evaluated, and the cellular phenotype within the fracture callus was examined.

Results

We observed Hic1+ progenitors at the fracture site at both 2‑ and 4‑wpi. Conditional deletion of Prg4 in these progenitors impaired the quality of new bone formation at the fracture site. Furthermore, PRG4 was required to maintain the cartilaginous phenotype of callus cells. In its absence, chondrocytes underwent premature transformation into osteoblasts, disrupting the normal progression of fracture healing.

Discussion

These findings provide new insights into the role of PRG4 in bone regeneration. PRG4, derived from Hic1+ MPCs, is critical for regulating the balance between chondrogenesis and osteogenesis during fracture repair. By preventing premature chondrocyte‑to‑osteoblast transition, PRG4 supports proper callus formation and bone healing. This work highlights the importance of PRG4 and Hic1+ MPCs in fracture repair and extends their known functions in tissue homeostasis and wound healing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fracture HealingMesenchymal Stem CellsProteoglycansOsteoblastsChondrocytesCell TransdifferentiationAnimalsMiceMaleProteoglycan 4

Stichwörter der Autor:innen

Prg4fracture healingmesenchymal progenitor cellstransdifferentiation

Substanzen

ProteoglycansPrg4 protein, mouseProteoglycan 4

Autor:innen und Institutionen

  • McCaig Institute for Bone & Joint Health, University of Calgary, Calgary, AB T2N4N1, Canada.
  • Department of Biomedical Engineering, University of Calgary, Calgary, AB T2N4N1, Canada.
  • Department of Radiology, University of Calgary, Calgary, AB T2N4N1, Canada.
  • Human Performance Laboratory, Faculty of Kinesiology, University of Calgary, Calgary, AB T2N4N1, Canada.
  • Department of Orthopaedic Surgery, University of California at San Francisco, San Francisco, CA 94110, United States.
  • Department of Biomedical Engineering, University of Connecticut Health Center, Farmington, CT 06030, United States.

ORCID-Profile: Roman J Krawetz

Förderung

  • Natural Sciences and Engineering Research Council (NSERC)
  • Canada Foundation for Innovation
  • Calgary Foundation
  • Grace Glaum Professorship
  • Canada Research Chairs

Zitieren

APA

Ninkovic, N., Corpuz, J. M., Stahl, A., Olsen, A., Unger, C. M., Ardebili, A. A., Sun, H., Cha, J., Kaketsis, D., Manske, S. L., Haider, I. T., Marcucio, R. S., Schmidt, T. A., Jay, G. D., Underhill, T. M., Edwards, W. B., Rancourt, D. E., Biernaskie, J., & Krawetz, R. J. (2025). Mesenchymal progenitor–derived proteoglycan 4 regulates the transdifferentiation of chondrocytes into osteoblasts during fracture healing. Stem Cells Translational Medicine, 14(9). https://doi.org/10.1093/stcltm/szaf043

Vancouver

Ninkovic N, Corpuz JM, Stahl A, Olsen A, Unger CM, Ardebili AA, et al. Mesenchymal progenitor–derived proteoglycan 4 regulates the transdifferentiation of chondrocytes into osteoblasts during fracture healing. Stem Cells Translational Medicine. 2025;14(9). doi:10.1093/stcltm/szaf043

BibTeX
@article{Ninkovic2025,
  author = {Ninkovic, Nicoletta and Corpuz, Jessica May and Stahl, Alana and Olsen, Alexandra and Unger, Colton M and Ardebili, Aria Ahadzadeh and Sun, Haochen and Cha, Juyeon and Kaketsis, Daphne and Manske, Sarah L and Haider, Ifaz T and Marcucio, Ralph S and Schmidt, Tannin A and Jay, Gregory D and Underhill, T Michael and Edwards, W Brent and Rancourt, Derrick E and Biernaskie, Jeff and Krawetz, Roman J},
  title = {Mesenchymal progenitor–derived proteoglycan 4 regulates the transdifferentiation of chondrocytes into osteoblasts during fracture healing},
  journal = {Stem Cells Translational Medicine},
  year = {2025},
  volume = {14},
  number = {9},
  doi = {10.1093/stcltm/szaf043}
}
Kostenlos starten →